Gregory J Salimando, Sébastien Tremblay, Blake A Kimmey, Jia Li, Sophie A Rogers, Jessica A Wojick, Nora M McCall, Lisa M Wooldridge, Amrith Rodrigues, Tito Borner, Kristin L Gardiner, Selwyn S Jayakar, Ilyas Singeç, Clifford J Woolf, Matthew R Hayes, Bart C De Jonghe, F Christian Bennett, Mariko L Bennett, Julie A Blendy, Michael L Platt, Kate Townsend Creasy, William R Renthal, Charu Ramakrishnan, Karl Deisseroth, Gregory Corder
With concurrent global epidemics of chronic pain and opioid use disorders, there is a critical need to identify, target and manipulate specific cell populations expressing the mu-opioid receptor (MOR). However, available tools and transgenic models for gaining long-term genetic access to MOR+ neural cell types and circuits involved in modulating pain, analgesia and addiction across species are limited. To address this, we developed a catalog of MOR promoter (MORp) based constructs packaged into adeno-associated viral vectors that drive transgene expression in MOR+ cells...
September 13, 2023: Nature Communications